Cart
sales@molnova.com
BTS
CAS No. 1576-37-0
BTS( N-Benzyl-p-toluenesulfonamide | N-Tosylbenzylamine )
Catalog No. M12252 CAS No. 1576-37-0
A highly specific myosin II ATPase inhibitor; inhibits the Ca2+-stimulated S1 ATPase, and reversibly blocked gliding motility.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameBTS
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly specific myosin II ATPase inhibitor; inhibits the Ca2+-stimulated S1 ATPase, and reversibly blocked gliding motility.
-
DescriptionA highly specific myosin II ATPase inhibitor; inhibits the Ca2+-stimulated S1 ATPase, and reversibly blocked gliding motility; inhibits isometric Ca2+-activated tension with IC50 of 3 uM in glycerol-extracted fibres from rabbit psoas muscle; specific and no activity for platelet myosin II.
-
In VitroBTS (2-12 μM) inhibits the Ca2+-stimulated ATPase activity of myosin S1 in the absence of actin, with an IC50 of ~5 μM.BTS (2-20 μM) reversibly inhibits the gliding motility rate of heavy meromyosin (HMM).BTS (100 μM) releases myosin from actin in the presence of ADP.BTS (0-20 μM) reversibly inhibits isometric Ca2+-activated tension in skinned skeletal muscle fibres from rabbit and frog, with IC50s of ~3 μM and 1 μM, respectively.
-
In Vivo——
-
SynonymsN-Benzyl-p-toluenesulfonamide | N-Tosylbenzylamine
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
RecptorMyosin
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1576-37-0
-
Formula Weight261.3394
-
Molecular FormulaC14H15NO2S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=S(C1=CC=C(C)C=C1)(NCC2=CC=CC=C2)=O
-
Chemical NameBenzenesulfonamide, 4-methyl-N-(phenylmethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cheung A, et al. Nat Cell Biol. 2002 Jan;4(1):83-8.
2. Blair DR, et al. Am J Physiol Endocrinol Metab. 2009 May;296(5):E993-E1002.
3. Abi-Gerges N, et al. J Mol Cell Cardiol. 2013 Nov;64:108-19.
molnova catalog
related products
-
Danicamtiv
Danicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
-
JB002
JB002, a myosin II inhibitor, exhibits potent activity with an IC50 of ≤10 μM. It holds potential for research applications in muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy.
-
BHC
BHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.
